Carmen M. Treacy

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response.

Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response.

Journal: bioRxiv : the preprint server for biology

Published: December 11, 2023

Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response.

Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response.

Journal: Nature cardiovascular research

Published: March 24, 2023

First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease.

First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease.

Journal: American journal of respiratory and critical care medicine

Published: July 19, 2022

Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.

Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: March 22, 2022

Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans.

Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans.

Journal: Cell death & disease

Published: November 11, 2021

Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival.

Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival.

Journal: Chest

Published: August 25, 2021

Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Journal: Genome medicine

Published: June 23, 2021

Bayesian Inference Associates Rare KDR Variants with Specific Phenotypes in Pulmonary Arterial Hypertension.

Bayesian Inference Associates Rare KDR Variants with Specific Phenotypes in Pulmonary Arterial Hypertension.

Journal: Circulation. Genomic and precision medicine

Published: December 15, 2020

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Journal: Genome medicine

Published: June 18, 2020

Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.

Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: October 30, 2019

Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.

Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.

Journal: Circulation. Genomic and precision medicine

Published: October 26, 2018

Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis.

Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis.

Journal: The European respiratory journal

Published: August 03, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026